Commensal bacteria produce GPCR ligands that mimic human signaling molecules
By Louis J. Cohen, D. Esterházy, Seong-Hwan Kim, C. Lemetre, R. Aguilar, Emma A. Gordon, Amanda J. Pickard, J. Cross, A. Emiliano, Sun M. Han and 8 more. Nature, 2017
361 citations recorded by the source corpus.
Commensal bacteria are believed to have important roles in human health. The mechanisms by which they affect mammalian physiology remain poorly understood, but bacterial metabolites are likely to be key components of host interactions. Here we use bioinformatics and synthetic biology to mine the human microbiota for N-acyl amides that interact with G-protein-coupled receptors (GPCRs). We found that N-acyl amide synthase genes are enriched in gastrointestinal bacteria and the lipids that they encode interact with GPCRs that regulate gastrointestinal tract physiology. Mouse and cell-based models demonstrate that commensal GPR119 agonists regulate metabolic hormones and glucose homeostasis as efficiently as human ligands, although future studies are needed to define their potential physiological role in humans. Our results suggest that chemical mimicry of eukaryotic signalling molecules may be common among commensal bacteria and that manipulation of microbiota genes encoding metabolites that elicit host cellular responses represents a possible small-molecule therapeutic modality (microbiome-biosynthetic gene therapy).
Subfields: Food Science, Molecular Biology, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/70eec4f52eeaf12939660dabdc3b1ff2e5f44213
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- American Gut: an Open Platform for Citizen Science Microbiome Research (2018, neutral): “322, has been annotated as N-3-OH-palmitoyl ornithine based on the exact mass and previous annotation (39) as well as analysis of fragmentation patterns to confirm structural moieties of fragments (Fig.”
- The gut microbiome: Relationships with disease and opportunities for therapy (2018, background): “These advances in high-throughput technologies have not only facilitated analyses of the composition and function of human-associated microbiomes, but they have also begun to reveal a diverse array of microbial-derived products that facilitate interspecies interactions in the human host (Rooks and G”